Antihemophilic Factor (Recombinant), Glycopegylated-Exei (Intravenous Route)

Name: Antihemophilic Factor (Recombinant), Glycopegylated-Exei (Intravenous Route)


Antihemophilic factor (recombinant), glycopegylated-exei injection is used to treat and control bleeding in patients with hemophilia A (congenital Factor VIII deficiency). It is also used to reduce the number of bleeding episodes in patients when used regularly. Antihemophilic factor (recombinant), glycopegylated-exei injection is also used to prevent bleeding during a surgical procedure.

This medicine is available only with your doctor's prescription.


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of antihemophilic factor (recombinant), glycopegylated-exei injection in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution and an adjustment in the dose for patients receiving this medicine.

Drug Interactions

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.